Assessing the Burden of Respiratory Syncytial Virus (RSV): the Assessment of the Burden of Respiratory Syncytial Virus (RSV) Across Different Age Groups and Risk Factors
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,500
- 试验地点
- 1
- 主要终点
- Burden of RSV Infection Across All Age Groups
研究概览
简要总结
This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand:
- How often does RSV occur
- Who is most at risk
- The long-term and financial effects of RSV
详细描述
This study is designed to analyze the impact of Respiratory Syncytial Virus (RSV) across different age groups. It focuses on how often RSV occurs, who is most at risk, and its long-term and financial effects. The study uses existing hospital records from SEHA facilities between January 2018 and December 2024. This is a retrospective observational study, meaning no new tests or treatments are given. Researchers look at medical records from past patients who were diagnosed with RSV. Anonymized data is collected from SEHA's Electronic Medical Records (EMR) and laboratory systems. Only patients with confirmed RSV infections are included.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients of all ages with a confirmed diagnosis of RSV infection
- •Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024
- •Patients with documented data in the SEHA electronic medical record (EMR) system
排除标准
- •Patients with suspected RSV infection that is not laboratory-confirmed
- •Patients without sufficient data in the SEHA EMR system
结局指标
主要结局
Burden of RSV Infection Across All Age Groups
时间窗: January 2018 - December 2024
Measurement of the prevalence of confirmed RSV infections in patients of all ages using SEHA hospital data from January 2018 to December 2024.
次要结局
- Identification of Risk Factors for Severe RSV Infection(January 2018 - December 2024)
- Proportion of Hospital Admissions Due to RSV(January 2018 - December 2024)
- ICU Admission Rates for RSV-Infected Patients(January 2018 - December 2024)
- RSV-Associated Mortality Rates(January 2018 - December 2024)
- Long-Term Respiratory Outcomes Following RSV Infection(Up to 12 months post-infection)
- Financial Burden of RSV Infection(January 2018 - December 2024)
- Incidence of Recurrent Wheezing and Asthma Diagnosis Following RSV Infection(Up to 12 months post-infection)